Viewing Study NCT03769168


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-25 @ 3:59 PM
Study NCT ID: NCT03769168
Status: COMPLETED
Last Update Posted: 2025-10-16
First Post: 2018-11-21
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Sponsor: Novartis Pharmaceuticals
Organization: